AU2003220931A1 - 2-pyrone compounds and use thereof - Google Patents

2-pyrone compounds and use thereof

Info

Publication number
AU2003220931A1
AU2003220931A1 AU2003220931A AU2003220931A AU2003220931A1 AU 2003220931 A1 AU2003220931 A1 AU 2003220931A1 AU 2003220931 A AU2003220931 A AU 2003220931A AU 2003220931 A AU2003220931 A AU 2003220931A AU 2003220931 A1 AU2003220931 A1 AU 2003220931A1
Authority
AU
Australia
Prior art keywords
pyrone compounds
pyrone
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003220931A
Inventor
Kiyoshi Higashi
Junya Takahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of AU2003220931A1 publication Critical patent/AU2003220931A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003220931A 2002-03-27 2003-03-20 2-pyrone compounds and use thereof Abandoned AU2003220931A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP2002088575 2002-03-27
JP2002-88575 2002-03-27
JP2002088574 2002-03-27
JP2002-88574 2002-03-27
JP2002290843 2002-10-03
JP2002-290843 2002-10-03
PCT/JP2003/003392 WO2003080592A1 (en) 2002-03-27 2003-03-20 2-pyrone compounds and use thereof

Publications (1)

Publication Number Publication Date
AU2003220931A1 true AU2003220931A1 (en) 2003-10-08

Family

ID=28457591

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003220931A Abandoned AU2003220931A1 (en) 2002-03-27 2003-03-20 2-pyrone compounds and use thereof

Country Status (2)

Country Link
AU (1) AU2003220931A1 (en)
WO (1) WO2003080592A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004274325B2 (en) * 2003-09-17 2011-11-10 Sumitomo Chemical Company, Limited Cinnamoyl compound and use of the same

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005028439A1 (en) * 2003-09-17 2005-03-31 Sumitomo Chemical Company, Limited Cinnamoyl compound and use of the same
US8524729B2 (en) 2003-09-17 2013-09-03 Sumitomo Chemical Company, Limited Cinnamoyl derivatives and use thereof
EP1721905A4 (en) * 2004-03-05 2009-11-18 Taisho Pharmaceutical Co Ltd Thiazole derivative
EP1857455A1 (en) * 2005-03-02 2007-11-21 Sumitomo Chemical Company, Limited Cinnamoyl compound and use thereof
JP2007308441A (en) * 2006-05-22 2007-11-29 Sumitomo Chemical Co Ltd Heterocycle-containing compound and its application

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS411412B1 (en) * 1963-02-27 1966-02-03
DE2728243A1 (en) * 1977-06-23 1979-01-11 Henkel Kgaa COSMETIC LIGHT PROTECTION AGENTS FOR THE UV-A AREA
EP0841063A1 (en) * 1996-03-27 1998-05-13 Toray Industries, Inc. Ketone derivatives and medicinal use thereof
JP2000342296A (en) * 1999-03-29 2000-12-12 Shiseido Co Ltd Evaluation of substance acting on transforming growth factor-beta 2 (tgf-beta 2)
EP1324993A2 (en) * 2000-04-18 2003-07-09 Cytovia, Inc. Substituted 1,4-thiazepine and analogs as activators of caspases and inducers of apoptosis and the use thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004274325B2 (en) * 2003-09-17 2011-11-10 Sumitomo Chemical Company, Limited Cinnamoyl compound and use of the same

Also Published As

Publication number Publication date
WO2003080592A1 (en) 2003-10-02

Similar Documents

Publication Publication Date Title
AU2003217870A1 (en) Pini-modulating compounds and methods of use thereof
AU2003225669A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003225668A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003226094A1 (en) Compounds and methods
AU2003213673A1 (en) Pin1-modulating compounds and methods of use thereof
GB0220214D0 (en) Compounds and their use
AU2003296369A1 (en) Imminoamines and preparation thereof
AU2002359694A1 (en) Compounds and methods
AU2003228198A1 (en) Av-fistula bandage
AU2003281691A1 (en) Furoisoquinoline derivative and use thereof
AU2003220931A1 (en) 2-pyrone compounds and use thereof
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AU2002953095A0 (en) Novel chemical compounds and their use
GB0227906D0 (en) Compounds and their use
AU2003302173A1 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
AU2003295057A1 (en) Novel lipophilic compounds and uses thereof
GB0230134D0 (en) Compounds and their use
AU2003216442A1 (en) Enkurin and uses thereof
AU2003228397A1 (en) HAUSP-p53 INTERACTION AND USES THEREOF
GB0218031D0 (en) Compounds and their use
AU2003223357A1 (en) Compounds and methods
AU2003255232A1 (en) Antigiardial agents and use thereof
AU2003906261A0 (en) Bis-cationic Compounds and Use Thereof
GB0220215D0 (en) Compounds and their use
AU2003294141A1 (en) Silicon-containing compounds and their use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase